The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma.
Park
Hae-Sim
HS
Kim
Seung-Hyun
SH
Sampson
Anthony P
AP
Lee
Kyung-Wha
KW
Park
Choon-Sik
CS
D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy* / Q000235:genetics; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D005819:Genetic Markers; D006682:HLA-DP Antigens / Q000235:genetics*; D059868:HLA-DP beta-Chains; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests
D018927:Anti-Asthmatic Agents; D005819:Genetic Markers; D006682:HLA-DP Antigens; D059868:HLA-DP beta-Chains; C071170:HLA-DPB1 antigen; D020024:Leukotriene Antagonists; D001241:Aspirin